Contact lens with embedded circuit is here to manage glaucoma. After helping the ophthalmologists of Europe and US, Sensimed has commenced its journey of APAC region

We are referring to recently inked deal of Sensimed with SEED from Japan. The duo longs to address and identify glaucoma issues at early stage.

Sensimed’s contact lens that goes by the name Triggerfish, measures the dimensional change of the eye for time duration of 24 hours. It then uploads this data into software via Bluetooth.  The data recorded is used in diagnosing and treating of glaucoma.

Sensimed had received CE mark in Sep 2009 and FDA nod in March, 2016. Unexplored APAC waters have recently been touched by Sensimed through its deal with SEED.

Sensimed’s company page has a phrase which says:

“The Company is directly positioned at the convergence between devices, treatment and information”.

We think with each day Sensimed is justifying this claim with much more vigour, while its accomplishments go about acknowledging the same.

Advertisements

This claim of Quintiles will take you back..

This claim of Quintiles will take you back…..

We are referring to company’s recently released image(below) on social platforms.ext.jpg

We all know how difficult it is to kick-start a clinical trial without hassle. Now Quintile’s this claim just goes about proving how capable and confident the company is.

Quintiles has been in limelight recently for many reasons. Some of them include acquisitions, award winning streak , tweaking research kit codes and others.

Looking into all this, there is no doubt that company would deliver on what it says. Its winning of best CRO title in Asia, 6 times in a row just goes about proving its best in class status is well earned one.

Further its acquisition of IMS and tweaking of research kit to use the app in clinical trial just acknowledges its understanding of future trends, and how it is on track to be a front runner in CRO industry.

Now coming to our initial statement , this claim of Quintiles was well expected one. Its precision enrolment program will get your trials started in 21 days.

So what are all the sponsors waiting for, go ahead try out this program and get the desired results in stipulated time frame.

 

For more updates on Healthcare, follow Medical Device Trends: Your On-line Trend Tracker

 

Alibaba looks to explore this new business venture out of the blue….

AAEAAQAAAAAAAAc1AAAAJDU4NTU3YjE0LTk2MTMtNGY2Ni04MzEzLTkyMzU2NGFiOGVkMQ.png

Alibaba looks to explore this new business venture out of the blue….

We are referring to companies plans to sell drugs on-line.

Yes you heard it right. Hong Kong listed Ali Health looks to tap into 65 drug store chain in order to mark its beginning in e-commerce drug sales.

Alibaba is revisiting this area again. In the past it had retracted its move on the account of speculated regulatory challenges that might come its way. Country’s regulatory agencies have given  nod for similar program (pilot basis) to Jo-Jo drug stores. Though the grant from regulatory agencies has not been around drugs on-line sales, its still a noteworthy accommodation that country’s regulatory bodies have given for on-line programs.

Initial venture of Ali Health will focus on service based model, which it eventually looks to take on e-commerce lane.

These activities are quiet a progress in drug distribution pathways in China region. However we can’t overlook the fact that we are talking about a region which had previously been questioned on it quality monitoring norms. With prescription sales being channelled through E-commerce gateway, country has to be over cautious in both monitoring and responding to surfacing issues.

 

For more trends update in healthcare space Follow Medical Device Trends ( Your On-line Trend Tracker)

India’s new development on device pricing-Boon or Bane for Make In India?

amin20111001112037123

India has been most watched emerging market for medical devices. Country houses right infrastructure, technical know-how, not to forget regulatory knowledge in comparison to all its peer nation involving China, Thailand, Taiwan, Malaysia and others.

The cherry on cake was PM Modi’s recent Make in India campaign which provides incentives to foreign manufacturers to manufacture in India and levy government support on tax and other reforms. Further, last year’s government eased policy to allow 100% FDI under the automatic route in this sector made the situation more favourable for Indian medtech industry.

Country houses right infrastructure, technical know-how, not to forget regulatory knowledge in comparison to all its peer nation involving China, Thailand, Taiwan, Malaysia and others.

This streamlined flow of activities witnessed a sudden break when government raised a concern demanding medical devices price capping. The authorities wanted essential medical devices that are flagged to critical care, to have their price contained in order to make the devices affordable for patients across country.

Teams flagged to the process are likely to sit on the same, and come to the conclusion of how they will balance patients and manufacturers expectation. While one requests for affordability other looks for making cash in order to promote innovation.

Governing bodies are stuck in dilemma, root cause of which comes from the fact seeded to price disparity between indigenous and foreign brands.Foreign manufacturers respond to this by putting the quality difference reason as explanation to higher price quotes.

Call on the final hearing is subjective, and has put the governing agencies at tough spot. As we await for the final call, the prevailing situation leaves a lot of room for discussion around what is ideal thing to do.

For more trends follow:

〈Medical Device Trends〉

Your On-line Trend Tracker

APAC Healthcare Landmarks: In 2015

APAC_World_Map

Image Source: Thomson Reuters

Ever changing healthcare industry behaved as expected in the year 2015. It embraced growth, looked at billion dollar M&A deals, expanded capacity, involved itself in cross industry partnerships and much more.

Developed markets continued to have steady growth while emerging markets remained potential targets.

Speaking of emerging markets, these markets not just welcomed venture of western companies, but in some cases welcomed new trends and policies too.

According Global Growth Markets feature, following were some landmark deal that geography experienced, in order to reach long awaited healthcare sector maturity.

We would like to bucket this trends under various categories namely:

  • IOT related
  • Demand and supply related
  • Regulations
  • Others

IOT

– aka. Big Data, aka. Telemedicine  included all the developments ranging from investment on e-health in Australia, to Singapore coming on board with I-PADS and other portals for patient rehabilitation. It was not just these regions that opened their arms for IOT and its associated products, regions such as China, Myanmar and other emerging markets also expressed interest to tap into extreme potentials of internet of things.

Demand and supply related

While emerging market growing demand is no myth, with their average figures witnessing a continuous growth Y-o-Y, some geographies such as Brazil surprised the industry by buying less of medical equipment than its previous fiscal year.

Supply on the other side was on better position from all the angles. GE plugged in USD 1 billion in Indonesia, Malaysia- came on medical device manufacturing map by scaling its international technical know how and providing right infrastructure and taxation norms to global companies.

Regulations

At regulation front, two important news that remained as talk of the town were:

1.India opening up for 100% FDI for medical device sector.

2.And China outlining regulatory norms for online sales of medicine.

Others

Besides aforementioned activities, ASIA also viewed formation of Asia Pacific Medical Device Association, a consortium formed by behemoths such as BD, Medtronic, Philips Healthcare and Others.

Read Original Content Here 

For More Updates – Follow Medical Device Trends

 

Note: Though the focus of the feature has been around APAC, regions such as Brazil are also outlined in the discussion.

Top med tech stories from previous day 20/03/2015

Medical device trends brings you top 3 stories from previous day. As these features remained at the forefront in terms of tweets , views and discussions, we bring you quick snapshot of their content. Below are top three stories purely based on their social media coverage, popularity and relevance:

Download your copy by clicking: Medical Device Trends News Letter (Daily Dossier)

Below is image snapshot of the same:

Medical Device Trends News Letter (Daily Dossier)

For more updates follow Medical Device Trends

Medical Device Trends
Your Online Trend Tracker
http://www.medicaldevicetrend.com